Tau oligomers and tau toxicity in neurodegenerative disease.

Tau oligomers and tau toxicity in neurodegenerative disease.
复制标题

DOI:
10.1042/bst20120134
复制
发表时间:
2012-08
影响因子:
3.9
通讯作者:
Binder LI
Binder LI
中科院分区:
生物学3区
文献类型:
--
作者:
Ward SM;Himmelstein DS;Lancia JK;Binder LI

文献摘要

被引文献

相似文献

AD(阿尔茨海默氏病)是一种进行性神经退行性疾病,其特征是细胞外β-淀粉样肽积累和细胞内tau蛋白积累。尽管有大量证据表明 tau 蛋白与神经退行性疾病有关,但 tau 蛋白介导的神经毒性的确切机制仍然难以捉摸。据报道,AD 脑组织中存在缺乏神经原纤维缠结的 tau 阳性前缠结神经元。为了研究这种非纤维状 tau,我们制备了一种新型单克隆抗体,命名为 TOC1(tau 寡聚复合物 1),它选择性标记 tau 二聚体和寡聚体,但不标记丝状体。时程分析和抗体标记表明寡聚物是 AD 发病机制中的早期事件。使用鱿鱼轴浆测定,我们证明聚集的 tau 蛋白会抑制顺行 FAT(快速轴突运输),而单体 tau 蛋白则没有效果。这种抑制需要一小段 N 端氨基酸,称为 PAD(磷酸酶激活结构域)。使用 PAD 特异性抗体 TNT1(tau N 末端 1),我们证明患病神经元中 PAD 暴露增加,这导致 FAT 抑制增加。抗体与早期 AD 标记 AT8 共标记表明,与 TOC1 类似,TNT1 表达代表 AD 发病机制的早期事件。最后,还在鱿鱼轴浆测定中研究了分子伴侣 Hsp70(热休克蛋白 70)的影响。我们证明,Hsp70 优先与 tau 寡聚体结合而不是细丝结合,并防止两种形式聚集 tau 的混合物观察到的顺行 FAT 抑制。总之,这些发现支持了这样的假设:tau 寡聚物是神经退行性疾病中 tau 的有毒形式。
AD (Alzheimer's disease) is a progressive neurodegenerative disorder characterized by the extracellular accumulation of amyloid β-peptide and the intracellular accumulation of tau. Although there is much evidence linking tau to neurodegeneration, the precise mechanism of tau-mediated neurotoxicity remains elusive. The presence of tau-positive pre-tangle neurons lacking neurofibrillary tangles has been reported in AD brain tissue. In order to study this non-fibrillar tau, we generated a novel monoclonal antibody, named TOC1 (tau oligomeric complex 1), which selectively labels tau dimers and oligomers, but does not label filaments. Time-course analysis and antibody labelling indicates that oligomers appear as an early event in AD pathogenesis. Using a squid axoplasm assay, we have demonstrated that aggregated tau inhibits anterograde FAT (fast axonal transport), whereas monomeric tau has no effect. This inhibition requires a small stretch of N-terminal amino acids termed the PAD (phosphatase-activation domain). Using a PAD-specific antibody, TNT1 (tau N-terminal 1), we demonstrate that PAD exposure is increased in diseased neurons and this leads to an increase in FAT inhibition. Antibody co-labelling with the early-AD marker AT8 indicates that, similar to TOC1, TNT1 expression represents an early event in AD pathogenesis. Finally, the effects of the molecular chaperone Hsp70 (heat-shock protein 70) were also investigated within the squid axoplasm assay. We illustrate that Hsp70 preferentially binds to tau oligomers over filaments and prevents anterograde FAT inhibition observed with a mixture of both forms of aggregated tau. Together, these findings support the hypothesis that tau oligomers are the toxic form of tau in neurodegenerative disease.